Inovalon Announces Converged Provider Enablement

3 years ago

A SaaS Solution that Aligns Disparate Quality, Risk, and Custom Value-Based Initiatives Across Multiple Provider Points of CareBOWIE, Md., March…

Privia Health and OhioHealth Health System Sign Definitive Partnership

3 years ago

ARLINGTON, Va. and COLUMBUS, Ohio, March 07, 2023 (GLOBE NEWSWIRE) -- Privia Health (Nasdaq: PRVA) and OhioHealth, a nationally recognized…

Elevar Therapeutics Debuts New Corporate Headquarters in Fort Lee, New Jersey

3 years ago

Presence in pharmaceutical industry hotbed allows Elevar to recruit top talent as it continues toward a commercial launch of cancer…

ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference

3 years ago

SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief…

F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma

3 years ago

Parties expect the merger to be completed promptly following the successful completion of the ongoing Tender OfferCAMBRIDGE, United Kingdom and…

Adaptive Research and AHMC Seton Medical Center Announce Collaboration to Expand Clinical Trial Access to Both In- and Out-Patient Settings

3 years ago

SAN FRANCISCO and DALY CITY, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Adaptive Research, an integrated clinical trial site organization…

Journey Medical Corporation to Participate in the 35th Annual ROTH Conference

3 years ago

SCOTTSDALE, Ariz., March 07, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage biopharmaceutical company that…

Cerevance Announces Upcoming Presentation at the Alzheimer’s Research UK Conference 2023 

3 years ago

BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel…

SELLAS Announces Publication of Positive GPS Clinical Data in Ovarian Cancer in Peer Reviewed Journal

3 years ago

Safety and Immunogenicity Examined in Phase 1 Trial of GPS plus Anti–PD-1 Nivolumab in Patients with WT1-Expressing Relapsed Ovarian Cancer…

Sofwave Medical to Participate in the Oppenheimer 33rd Annual Healthcare Conference

3 years ago

SAN CLEMENTE, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive,…